Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Subjective well-being across the life course among non-industrialized populations

  • Gurven, Michael|||0000-0002-5661-527X
  • Buoro, Yoann|||0009-0004-0058-4971
  • Rodriguez, Daniel Eid|||0000-0001-8145-0967
  • Sayre, Katherine|||0000-0003-2554-4058
  • Trumble, Benjamin|||0000-0003-3201-0628
  • Pyhälä, Aili|||0000-0001-7095-5994
  • Kaplan, Hillard|||0000-0002-7398-7358
  • Angelsen, Arild|||0000-0002-6037-6849
  • Stieglitz, Jonathan|||0000-0001-5985-9643
  • Reyes-García, Victoria|||0000-0002-2914-8055
Subjective well-being (SWB) is often described as being U-shaped over adulthood, declining to a midlife slump and then improving thereafter. Improved SWB in later adulthood has been considered a paradox given age-related declines in health and social losses. While SWB has mostly been studied in high-income countries, it remains largely unexplored in rural subsistence populations lacking formal institutions that reliably promote social welfare. Here, we evaluate the age profile of SWB among three small-scale subsistence societies (n = 468; study 1), forest users from 23 low-income countries (n = 6987; study 2), and Tsimane' horticulturalists (n = 1872; study 3). Across multiple specifications, we find variability in SWB age profiles. In some cases, we find no age-related differences in SWB or even inverted U-shapes. Adjusting for confounders reduces observed age effects. Our findings highlight variability in average well-being trajectories over the life course. Ensuring successful aging will require a greater focus on cultural and socioecological determinants of individual trajectories.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program

  • Janin, Maxime
  • Ortiz‑Barahona, Vanessa
  • Castro de Moura, Manuel
  • Martínez‑Cardús, Anna
  • Llinàs‑Arias, Pere
  • Soler, Marta
  • Arias Piñeiro, Alexandra
  • Cuartas Maza, Ma Isabel
  • Seoane Suarez, Joan
Resultado clínico; Epitranscriptómica; Glioma, Clinical outcome; Epitranscriptomics; Glioma, Resultat clínic; Epitranscriptòmica; Glioma, Tumors have aberrant proteomes that often do not match their corresponding transcriptome profiles. One possible cause of this discrepancy is the existence of aberrant RNA modification landscapes in the so-called epitranscriptome. Here, we report that human glioma cells undergo DNA methylation-associated epigenetic silencing of NSUN5, a candidate RNA methyltransferase for 5-methylcytosine. In this setting, NSUN5 exhibits tumor-suppressor characteristics in vivo glioma models. We also found that NSUN5 loss generates an unmethylated status at the C3782 position of 28S rRNA that drives an overall depletion of protein synthesis, and leads to the emergence of an adaptive translational program for survival under conditions of cellular stress. Interestingly, NSUN5 epigenetic inactivation also renders these gliomas sensitive to bioactivatable substrates of the stress-related enzyme NQO1. Most importantly, NSUN5 epigenetic inactivation is a hallmark of glioma patients with long-term survival for this otherwise devastating disease., This work was supported by a European Research Council (ERC) Advanced Grant under the European Community’s Seventh Framework Program (FP7/2007-2013)/ERC Grant Agreement No. 268626—EPINORC project (to M. Esteller), the Ministerio de Economía y Competitividad (MINECO) under Grant No. SAF2014-55000-R (to M. Esteller) and the Instituto de Salud Carlos III (ISCIII), under the FIS PI16/01278 Project (to J. Seoane), the Integrated Project of Excellence no. PIE13/00022 (ONCOPROFILE) (to M. Esteller), CIBER 2016 CB16/12/00312 (CIBERONC) (to M. Esteller), co-financed by the European Development Regional Fund, ‘A way to achieve Europe’ ERDF, the AGAUR—Catalan Government (Project No. 2009SGR1315 and 2014SGR633) (to M. Esteller), the Cellex Foundation (to M. Esteller), Obra Social “La Caixa” (to M. Esteller), the CERCA Program and the Health and Science Departments of the Catalan Government (Generalitat de Catalunya) (to M. Esteller) and a grant from the National Health and Medical Research Council of Australia (APP1061551, to TP). M.W. Boudreau is a member of the NIH Chemistry-Biology Interface Training Program (T32-GM070421).
Archivo Digital UPM
Publication Contribución de congreso (ConferenceOutput)

Towards efficient processing of RDF Data Streams

  • Llaves Arellano, Alejandro
  • Corcho, Oscar|||0000-0002-9260-0753
  • Fernández García, Javier D.
Archivo Digital UPM
Publication Contribución de congreso (ConferenceOutput)

Learning low inference complexity Bayesian networks

  • Benjumeda Barquita, Marco|||0000-0001-6681-1699
  • Larrañaga Múgica, Pedro María|||0000-0003-0652-9872
  • Bielza Lozoya, María Concepción|||0000-0001-7109-2668
Archivo Digital UPM
Publication Contribución de congreso (ConferenceOutput)

Latent force models for earth observation time series prediction

Archivo Digital UPM
Publication Contribución de congreso (ConferenceOutput)

Hybrid Gaussian and von Mises model-based clustering

  • Luengo Sánchez, Sergio|||0000-0001-8537-1879
  • Larrañaga Múgica, Pedro María|||0000-0003-0652-9872
  • Bielza Lozoya, María Concepción|||0000-0001-7109-2668
Archivo Digital UPM
Publication Contribución de congreso (ConferenceOutput)

Learning tractable multidimensional Bayesian network classifiers

  • Benjumeda Barquita, Marco|||0000-0001-6681-1699
  • Larrañaga Múgica, Pedro María|||0000-0003-0652-9872
  • Bielza Lozoya, María Concepción|||0000-0001-7109-2668
Archivo Digital UPM
Publication Contribución de congreso (ConferenceOutput)

Multi-Key homomorphic authenticators

Archivo Digital UPM
Publication Artículo científico (JournalArticle)

PyramidalExplorer: a new interactive tool to explore morpho-functional relations of human pyramidal neurons

  • Toharia Rabasco, Pablo|||0000-0003-2429-1300
  • Robles Sánchez, Óscar David|||0000-0002-3881-7273
  • Fernaud Espinosa, Isabel|||0000-0003-2391-0704
  • Makarova, Julia|||0000-0001-9307-6167
  • Galindo Ruedas, Sergio
  • Rodríguez Martínez de Bartolomé, Ángel|||0000-0002-5145-5676
  • Pastor Pérez, Luis|||0000-0002-7900-7509
  • Herreras Espinosa, Óscar
  • Felipe Oroquieta, Javier de|||0000-0001-5484-0660
  • Benavides Piccione, Ruth|||0000-0003-3288-9820
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

BDNF Val66Met gene polymorphism modulates brain activity following rTMS-induced memory impairment

  • Abellaneda Pérez, Kilian|||0000-0001-6447-1248
  • Martin-Trias, Pablo
  • Cassé-Perrot, Catherine
  • Vaqué-Alcázar, Lídia|||0000-0002-6776-6559
  • Lanteaume, Laura
  • Solana, Elisabeth|||0000-0001-7973-2439
  • Babiloni, Claudio|||0000-0002-5245-9839
  • Lizio, Roberta|||0000-0003-1262-3689
  • Junqué, Carme|||0000-0002-6381-3063
  • Bargalló, Núria|||0000-0001-6284-5402
  • Rossini, Paolo Maria
  • Micallef, Joëlle
  • Truillet, Romain
  • Charles, Estelle
  • Jouve, Elisabeth|||0000-0002-4873-6522
  • Bordet, Régis|||0000-0003-3916-6422
  • Santamaria, Joan
  • Rossi, Simone|||0000-0001-6697-9459
  • Pascual Leone, Álvaro|||0000-0001-8975-0382
  • Blin, Olivier
  • Richardson, Jill|||0000-0001-6564-3187
  • Jovicich, Jorge|||0000-0001-9504-7503
  • Bartrés-Faz, David|||0000-0001-6020-4118
The BDNF Val66Met gene polymorphism is a relevant factor explaining inter-individual differences to TMS responses in studies of the motor system. However, whether this variant also contributes to TMS-induced memory effects, as well as their underlying brain mechanisms, remains unexplored. In this investigation, we applied rTMS during encoding of a visual memory task either over the left frontal cortex (LFC; experimental condition) or the cranial vertex (control condition). Subsequently, individuals underwent a recognition memory phase during a functional MRI acquisition. We included 43 young volunteers and classified them as 19 Met allele carriers and 24 as Val/Val individuals. The results revealed that rTMS delivered over LFC compared to vertex stimulation resulted in reduced memory performance only amongst Val/Val allele carriers. This genetic group also exhibited greater fMRI brain activity during memory recognition, mainly over frontal regions, which was positively associated with cognitive performance. We concluded that BDNF Val66Met gene polymorphism, known to exert a significant effect on neuroplasticity, modulates the impact of rTMS both at the cognitive as well as at the associated brain networks expression levels. This data provides new insights on the brain mechanisms explaining cognitive inter-individual differences to TMS, and may inform future, more individually-tailored rTMS interventions.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cold stress protein RBM3 responds to hypothermia and is associated with good stroke outcome

  • Ávila-Gómez, Paulo
  • Vieites-Prado, Alba
  • Dopico-López, Antonio
  • Bashir, Saima
  • Fernández-Susavila, Héctor
  • Gubern, Carme|||0000-0001-8378-4477
  • Pérez-Mato, María
  • Correa-Paz, Clara
  • Iglesias-Rey, Ramón|||0000-0002-9985-9135
  • Sobrino, Tomás|||0000-0002-9760-8690
  • Bustamante, Alejandro|||0000-0003-4390-8900
  • Wellmann, Sven
  • Montaner, Joan|||0000-0003-4845-2279
  • Serena, Joaquín|||0000-0002-4478-7744
  • Castillo, José
  • Hervella, Pablo|||0000-0003-1249-6333
  • Campos, Francisco|||0000-0001-8665-1039
RNA-binding motif protein 3 is a molecular marker of hypothermia that has proved neuroprotective in neurodegenerative disease models. However, its relationship to the well-recognized therapeutic effect of hypothermia in ischaemic stroke had not been studied. In this work, the expression of RNA-binding motif protein 3 was investigated in ischaemic animal models subjected to systemic and focal brain hypothermia, specifically the effects of RNA-binding motif protein 3 silencing and overexpression on ischaemic lesions. Moreover, the association of RNA-binding motif protein 3 levels with body temperature and clinical outcome was evaluated in two independent cohorts of acute ischaemic stroke patients (n = 215); these levels were also determined in a third cohort of 31 patients derived from the phase III EuroHYP-1 trial of therapeutic cooling in ischaemic stroke. The preclinical data confirmed the increase of brain RNA-binding motif protein 3 levels in ischaemic animals subjected to systemic and focal hypothermia; this increase was selectively higher in the cooled hemisphere of animals undergoing focal brain hypothermia, thus confirming the direct effect of hypothermia on RNA-binding motif protein 3 expression, while RNA-binding motif protein 3 up-regulation in ischaemic brain regions led to functional recovery. Clinically, patients with body temperature <37.5°C in the first two cohorts had higher RNA-binding motif protein 3 values at 24 h and good outcome at 3 months post-ischaemic stroke, while RNA-binding motif protein 3 levels in the cooled third cohort tended to exceed those in placebo-treated patients. These results make RNA-binding motif protein 3 a molecular marker associated with the effect of hypothermia in ischaemic stroke and suggest its potential application as a promising protective target. Hypothermia is an effective neuroprotective treatment in stroke. We have demonstrated that the expression of RBM3 is increased under hypothermia treatment in animal models of ischaemia and stroke patients. These results evidence the potential application of RBM3 as a promising protective target against ischaemia
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The involvement of medical doctors in hospital governance and implications for quality management, a quick scan in 19 and an in depth study in 7 OECD countries

  • Rotar, A. M.
  • Botje, Daan|||0000-0002-2374-8762
  • Klazinga, Niek|||0000-0002-3937-8014
  • Lombarts, Kiki|||0000-0001-6167-0620
  • Groene, Oliver|||0000-0002-1099-2950
  • Suñol Sala, Rosa|||0000-0003-1902-833X
  • Plochg, Thomas
Hospital governance is broadening its orientation from cost and production controls towards 'improving performance on clinical outcomes'. Given this new focus one might assume that doctors are drawn into hospital management across OECD countries. Hospital performance in terms of patient health, quality of care and efficiency outcomes is supposed to benefit from their involvement. However, international comparative evidence supporting this idea is limited. Just a few studies indicate that there may be a positive relationship between medical doctors being part of hospital boards, and overall hospital performance. More importantly, the assumed relationship between these so-called doctor managers and hospital performance has remained a 'black-box' thus far. However, there is an increasing literature on the implementation of quality management systems in hospitals and their relation with improved performance. It seems therefore fair to assume that the relation between the involvement of doctors in hospital management and improved hospital performance is partly mediated via quality management systems. The threefold aim of this paper is to 1) perform a quick scan of the current situation with regard to doctor managers in hospital management in 19 OECD countries, 2) explore the phenomenon of doctor managers in depth in 7 OECD countries, and 3) investigate whether doctor involvement in hospital management is associated with more advanced implementation of quality management systems. This study draws both on a quick scan amongst country coordinators in OECD's Health Care Quality Indicator program, and on the DUQuE project which focused on the implementation of quality management systems in European hospitals. This paper reports two main findings. First, medical doctors fulfil a broad scope of managerial roles at departmental and hospital level but only partly accompanied by formal decision making responsibilities. Second, doctor managers having more formal decision making responsibilities in strategic hospital management areas is positively associated with the level of implementation of quality management systems. Our findings suggest that doctors are increasingly involved in hospital management in OECD countries, and that this may lead to better implemented quality management systems, when doctors take up managerial roles and are involved in strategic management decision making.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Topological Data Analysis and its usefulness for precision medicine studies

  • Iniesta, Raquel|||0000-0003-1153-5417
  • Carr, Ewan|||0000-0002-1146-4922
  • Carrière, Mathieu|||0000-0002-4747-9915
  • Yerolemou, Naya|||0000-0003-3718-7270
  • Michel, Bertrand|||0000-0002-5901-4146
  • Chazal, Frédéric|||0000-0002-3719-2187
Precision medicine allows the extraction of information from complex datasets to facilitate clinical decision-making at the individual level. Topological Data Analysis (TDA) offers promising tools that complement current analytical methods in precision medicine studies. We introduce the fundamental concepts of the TDA corpus (the simplicial complex, the Mapper graph, the persistence diagram and persistence landscape). We show how these can be used to enhance the prediction of clinical outcomes and to identify novel subpopulations of interest, particularly applied to understand remission of depression in data from the GENDEP clinical trial.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Replication study of plasma proteins relating to Alzheimer's pathology

  • Shi, Liu|||0000-0003-1752-0419
  • Winchester, Laura|||0000-0003-3826-7694
  • Westwood, Sarah|||0000-0003-0506-7813
  • Baird, Alison L.
  • Anand, Sneha N.
  • Buckley, Noel J.|||0000-0003-1152-0653
  • Hye, Abdul|||0000-0003-2237-4823
  • Ashton, Nicholas J.|||0000-0002-3579-8804
  • Bos, Isabelle|||0000-0001-9648-6428
  • Vos, Stephanie J.B.|||0000-0002-2045-9818
  • ten Kate, Mara|||0000-0002-8290-8543
  • Scheltens, Philip|||0000-0002-1046-6408
  • Teunissen, Charlotte E.|||0000-0002-4061-0837
  • Vandenberghe, Rik|||0000-0001-6237-2502
  • Gabel, Silvy
  • Meersmans, Karen
  • Engelborghs, Sebastiaan|||0000-0003-0304-9785
  • De Roeck, Ellen
  • Sleegers, Kristel|||0000-0002-0283-2332
  • Frisoni, Giovanni B.|||0000-0002-6419-1753
  • Blin, Olivier
  • Richardson, Jill|||0000-0001-6564-3187
  • Bordet, Régis|||0000-0003-3916-6422
  • Molinuevo, José Luis|||0000-0003-0485-6001
  • Rami Gonzalez, Lorena|||0000-0002-7411-1921
  • Wallin, Anders|||0000-0001-9506-0513
  • Kettunen, Petronella|||0000-0002-2510-3423
  • Tsolaki, Magda|||0000-0002-2072-8010
  • Verhey, Frans
  • Lleó, Alberto|||0000-0002-2568-5478
  • Sala Matavera, Isabel|||0000-0002-9886-4792
  • Popp, Julius|||0000-0002-0068-0312
  • Peyratout, Gwendoline
  • Martinez-Lage, Pablo|||0000-0001-5404-9967
  • Tainta, Mikel|||0000-0003-0624-1211
  • Johannsen, Peter
  • Freund-Levi, Yvonne|||0000-0001-6863-6679
  • Froelich, Lutz|||0000-0003-1494-0813
  • Dobricic, Valerija|||0000-0001-8559-1097
  • Legido-Quigley, Cristina|||0000-0002-4018-214X
  • Barkhof, Frederik|||0000-0003-3543-3706
  • Andreasson, Ulf
  • Blennow, Kaj|||0000-0002-1890-4193
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Streffer, Johannes Rolf|||0000-0002-9387-5951
  • Lill, Christina|||0000-0002-2805-1307
  • Bertram, Lars|||0000-0002-0108-124X
  • Visser, Pieter Jelle|||0000-0001-8008-9727
  • Kolb, Hartmuth C.
  • Narayan, Vaibhav A.
  • Lovestone, Simon|||0000-0003-0473-4565
  • Nevado-Holgado, Alejo|||0000-0001-9276-2720
Introduction: This study sought to discover and replicate plasma proteomic biomarkers relating to Alzheimer's disease (AD) including both the "ATN" (amyloid/tau/neurodegeneration) diagnostic framework and clinical diagnosis. Methods: Plasma proteins from 972 subjects (372 controls, 409 mild cognitive impairment [MCI], and 191 AD) were measured using both SOMAscan and targeted assays, including 4001 and 25 proteins, respectively. Results: Protein co-expression network analysis of SOMAscan data revealed the relation between proteins and "N" varied across different neurodegeneration markers, indicating that the ATN variants are not interchangeable. Using hub proteins, age, and apolipoprotein E ε4 genotype discriminated AD from controls with an area under the curve (AUC) of 0.81 and MCI convertors from non-convertors with an AUC of 0.74. Targeted assays replicated the relation of four proteins with the ATN framework and clinical diagnosis. Discussion: Our study suggests that blood proteins can predict the presence of AD pathology as measured in the ATN framework as well as clinical diagnosis.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program

  • Janin, Maxime
  • Ortiz‑Barahona, Vanessa
  • Castro de Moura, Manuel
  • Martínez‑Cardús, Anna
  • Llinàs‑Arias, Pere
  • Soler, Marta
  • Arias Piñeiro, Alexandra
  • Cuartas Maza, Ma Isabel
  • Seoane Suarez, Joan
Resultado clínico; Epitranscriptómica; Glioma, Clinical outcome; Epitranscriptomics; Glioma, Resultat clínic; Epitranscriptòmica; Glioma, Tumors have aberrant proteomes that often do not match their corresponding transcriptome profiles. One possible cause of this discrepancy is the existence of aberrant RNA modification landscapes in the so-called epitranscriptome. Here, we report that human glioma cells undergo DNA methylation-associated epigenetic silencing of NSUN5, a candidate RNA methyltransferase for 5-methylcytosine. In this setting, NSUN5 exhibits tumor-suppressor characteristics in vivo glioma models. We also found that NSUN5 loss generates an unmethylated status at the C3782 position of 28S rRNA that drives an overall depletion of protein synthesis, and leads to the emergence of an adaptive translational program for survival under conditions of cellular stress. Interestingly, NSUN5 epigenetic inactivation also renders these gliomas sensitive to bioactivatable substrates of the stress-related enzyme NQO1. Most importantly, NSUN5 epigenetic inactivation is a hallmark of glioma patients with long-term survival for this otherwise devastating disease., This work was supported by a European Research Council (ERC) Advanced Grant under the European Community’s Seventh Framework Program (FP7/2007-2013)/ERC Grant Agreement No. 268626—EPINORC project (to M. Esteller), the Ministerio de Economía y Competitividad (MINECO) under Grant No. SAF2014-55000-R (to M. Esteller) and the Instituto de Salud Carlos III (ISCIII), under the FIS PI16/01278 Project (to J. Seoane), the Integrated Project of Excellence no. PIE13/00022 (ONCOPROFILE) (to M. Esteller), CIBER 2016 CB16/12/00312 (CIBERONC) (to M. Esteller), co-financed by the European Development Regional Fund, ‘A way to achieve Europe’ ERDF, the AGAUR—Catalan Government (Project No. 2009SGR1315 and 2014SGR633) (to M. Esteller), the Cellex Foundation (to M. Esteller), Obra Social “La Caixa” (to M. Esteller), the CERCA Program and the Health and Science Departments of the Catalan Government (Generalitat de Catalunya) (to M. Esteller) and a grant from the National Health and Medical Research Council of Australia (APP1061551, to TP). M.W. Boudreau is a member of the NIH Chemistry-Biology Interface Training Program (T32-GM070421).